Dual Path Platform (DPP) Vet Tuberculosis (TB) Assay Kits
Closed Pre-Solicitation Posted
- Solicitation number
- 1161063
- Agency
- Marketing and Regulatory Programs Business Services Animal and Plant Health Inspection Service, Department of Agriculture
- Responses due
- Set-aside
- No set-aside
Opportunity facts
- NAICS code
- 325413 In-Vitro Diagnostic Substance Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Place of performance
- Iowa 50010, United States
- Points of contact
-
- Kathy Melby kathleen.melby@usda.gov
Notice details come from SAM.gov. Updated .
About this opportunity
The Department of Agriculture's Animal and Plant Health Inspection Service (APHIS) is procuring Dual Path Platform (DPP) Vet Tuberculosis Assay kits, which are single-use immune-chromatographic tests designed to detect antibodies to Mycobacterium Bovis in cervid samples. These kits serve as the official test for the Federal Bovine Tuberculosis Eradication program and are used for tuberculosis diagnosis in conjunction with other diagnostic methods. The acquisition will utilize simplified procedures under FAR 12.201-1, and APHIS has justified restricting competition under FAR 6.302-1 based on the unique qualifications of the product and sole responsible source. All responsible sources are invited to submit responses, which should be emailed to Kathy Melby at Kathleen.Melby@usda.gov no later than January 21, 2026. The anticipated award date is January 22, 2026.
This procurement includes no set-aside designation. Chembio Diagnostic Systems, Inc., located in Medford, New York, is identified as the sole-source contractor and currently holds the only licensed test kit approved for detecting antibodies in cervids for bovine tuberculosis as part of the TB eradication program. The Cervid DPP test is the only product with authorization to be used within this federal program, establishing the basis for the sole-source justification. No specific contract value, quantity requirements, or service timeline details are disclosed in the pre-solicitation notice. The procurement falls under NAICS code 325413 (In-Vitro Diagnostic Substance Manufacturing) and PSC code 6505 (Drugs and Biologicals).
Notice text
This requirement is for Dual Path Platform (DPP) Vet Tuberculosis (TB) Assay kits. These are single use immune-chromatographic tests for detection of antibodies to Mycobacterium Bovis in cervid samples and is the official test for the Federal Bovine Tuberculosis Eradication program. The test is used for the diagnosis of tuberculosis in conjunction with other diagnostic methods. quantitative analysis.
RFO FAR 12.201-1 Simplified procedures will be used for awarding this contract. The anticipated award date is January 22, 2026.
The intended source for this acquisition is Chembio Diagnostic Systems, Inc.
The proposed contractor, Chembio Diagnostic Systems, Inc. is the only company that currently has a licensed test kit to detect antibodies in cervids for bovine tuberculosis. Chembio’s Cervid DPP is the only test that has approval to be used as part of the TB eradication program.
All responsible sources may submit a response which will be considered by the agency. Please email responses to Kathy Melby at Kathleen.melby@usda.gov no later than the response date of this notice. Telephonic inquiries will not be honored.
Attachments
| File | Type | Posted |
|---|---|---|
| Justification - DPP VetTB Assay Kits Complete.pdf |
On GovTribe
Work this opportunity on GovTribe
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity